Table 3.
Disease activity scoresc | CPa9-HNE | Faecal CP | MRP8/14 | Neutrophil count | CRP | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CDb | UCa | CDb | UCa | CDb | UCa | CDb | UCa | CDb | UCa | |||||||||||
r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | r-value | p-value | |
SES-CD | 0.61 | <0.0001 | 0.46 | 0.0023 | 0.018 | 0.89 | 0.22 | 0.11 | 0.29 | 0.0289 | ||||||||||
Full Mayo score | 0.60 | <0.0001 | 0.53 | 0.001 | 0.14 | 0.41 | 0.33 | 0.0343 | 0.54 | 0.004 | ||||||||||
MES | 0.53 | 0.0048 | 0.33 | 0.092 | 0.07 | 0.68 | 0.30 | 0.11 | 0.42 | 0.0189 | ||||||||||
pMayo score | 0.51 | 0.001 | 0.56 | 0.0005 | 0.21 | 0.21 | 0.34 | 0.0342 | 0.53 | 0.005 | ||||||||||
Truelove & Witts | 0.63 | <0.0001 | 0.63 | <0.0001 | 0.33 | 0.0422 | 0.36 | 0.0253 | 0.68 | <0.0001 | ||||||||||
SES-CD | 0.39 | 0.0201 | 0.35 | 0.0300 | -0.013 | 0.93 | 0.27 | 0.0675 | 0.29 | 0.0743 | ||||||||||
Full Mayo score | 0.63 | <0.0001 | 0.49 | 0.0042 | 0.18 | 0.32 | 0.28 | 0.12 | 0.55 | 0.005 | ||||||||||
MES | 0.57 | 0.0040 | 0.35 | 0.085 | 0.009 | 0.96 | 0.26 | 0.23 | 0.41 | 0.0433 | ||||||||||
pMayo score | 0.51 | 0.0028 | 0.49 | 0.0041 | 0.22 | 0.23 | 0.23 | 0.20 | 0.54 | 0.0009 | ||||||||||
Truelove & Witts | 0.52 | 0.0035 | 0.78 | <0.0001 | 0.37 | 0.047 | 0.35 | 0.058 | 0.72 | <0.0001 |
CD, Crohn’s disease; UC, ulcerative colitis; CP, calprotectin; SES-CD, Simple Endoscopic Score of Severity for CD; MES, Mayo Endoscopic Score; CRP, C-reactive protein.
The biomarker was not normally distributed and the Spearman rho correlation was applied.
The biomarker was normally distributed and the Pearson correlation was applied.
Paired serum and faecal samples.